Pediculus Humanus

Total Page:16

File Type:pdf, Size:1020Kb

Pediculus Humanus Studies into the insecticidai activity and mode of action of monoterpenoid constituents of essentiai oiis against the human iouse, Pediculus humanus. A thesis presented by Caroline Mary Priestley For the degree of Doctor of Philosophy Centre for Pharmacognosy and Phytotherapy, Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, Faculty of Medicine, University of London. 2002 Abstract The incidence of head lice, 'Pediculus humanus capitis^ in the West is increasing, with insecticide resistance the likely cause. Previous studies have explored the utility of essential oils, and some of their constituent monoterpenoids, in the treatment of head lice. This investigation examines the relative short-term toxicity of a range of different monoterpenoid structures on adult clothing lice, Pediculus humanus corporis, and their eggs; a structure-activity series was generated for the adults, and partially for eggs. The most effective monoterpenoid against adult Hce was (+)-terpinen-4-ol, with monocyclic compounds containing a single O-atom having the highest activities. Furthermore, there appear to be important differences between the relative potencies of monoterpenoids on lice and eggs, as nerolidol was particularly effective against eggs but completely ineffective against adult lice. To investigate the insecticidal mechanism of action of monterpenoids, various pediculicidal structures were screened for activity on an insect ionotropic GABA receptor, composed of the Drosophila melanogaster svhum t RDL^^, expressed in Xenopus oocytes. Thymol, eugenol and carvacrol potentiated GABA responses at this receptor, and possessed agonist activity at high concentrations. This is the first documentation of monoterpenoid bioactivity at an isolated insect receptor known to be representative of an in vivo insecticidal target. Thymol also had potentiating and agonist effects on human al|33Y2s GABA^ receptors expressed in Xenopus oocytes, and 50 p,M thymol induced a leftwards shift of the GABA dose-response curve. Further work on this receptor examined the interaction of thymol with previously characterised modulator binding sites. The results of functional studies suggest that thymol does not share a binding site with benzodiazepines, barbiturates, steroids, propofol, (3-carbolines or loreclezole. The direct involvement of insect GABA receptors in monoterpenoid insecticidal activity remains to be confirmed, as does the location of the thymol binding site on insect and mammalian ionotropic GABA receptors. Acknowledgements I am very grateful to my supervisor, Dr Elizabeth Williamson, for her guidance, support and enthusiasm throughout the course of my studies. I would also like to thank my collaborators, Mr Ian Burgess and Dr John Maunder (MEG Ltd, Cambridge), Dr David Sattelle (MRC Functional Genetics Unit, Oxford University) and Dr Keith Wafford (Merck, Sharp and Dohme, Terling’s Park, U.K.) for allowing me to work in their laboratories and for supplying specialist equipment and advice. I also thank my second supervisor. Professor Michael Heinrich for encouragement and his successful regeneration of the Centre for Pharmacognosy and Phytotherapy at The University of London School of Pharmacy. I must also thank the following people for their scientific advice: Dr Emmanuel Culetto and Dr Valerie Raymond (MRC Functional Genetics Unit, Oxford University), Dr Nigel Mongan (formerly of The Babraham Institute, University of Cambridge), Dr Lucy Horoszock (formerly a visitor to The Babraham Institute, University of Cambridge), Dr Michael Postlethwaite, Mr Gus Ronngren (The School of Pharmacy, University of London), Miss Rachael Cooper, Miss Beth Basham, and Mr David Thompson (MEC Ltd). Special thanks go to Mike & Rita Priestley, Matt Southward, Nic Newling, Nessie Ramm and Suzy Vaughan-Schiele for their out-of-hours support. This research was funded by a School of Pharmacy Studentship and a University of London Central Research Fund Grant Contents Abstract____________________________________________________________________2 Acknowledgements__________________________________________________________3 C ontents___________________________________________________________________4 Table of Figures____________________________________________________________7 Chapter 1 Introduction_______________________________________________________8 1.1 Concepts of head louse control _____________________________________________8 1.2 The taxonomy and anatomy of human lice and their interrelationship _____________9 1.3 The life cycle and population structure of Pediculus species____________________12 1.4 Symptoms and consequences of pediculosis capitis____________________________13 1.5 Transmission and epidemiology of Pediculus humanus capitis___________________16 1.6 Methods to control Pediculus humanus capitis_______________________________18 1.6.1 Historical aspects of louse control_______________________________________________________18 1.6.2 Resistance group 1 pediculicides: DDT and related compounds_____________________________19 1.6.3 Resistance group 11 pediculicides: The cyclodienes and cyclohexanes_______________________19 1.6.4 Resistance group 111 pediculicides: The organophosphates________________________________20 1.6.5 Resistance group IVpediculicides: The carbamates_______________________________________21 1.6.6 Resistance group Vpediculicides: The pyrethrins andpyrethroids__________________________22 1.6.7 Miscellaneous louse control methods____________________________________________________25 1.7 Shortcomings of head lice treatments ______________________________________26 1.7.1 Insecticide resistance__________________________________________________________________26 1.7.2 Toxicity towards humans _______________________________________________________________29 1.7.3 Incomplete ovicidal activity____________________________________________________________30 1.7.4 Product formulation___________________________________________________________________30 1.7.5 Treatment utilisation___________________________________________________________________31 1.8 Will more pediculicidal agents help to control head lice? _______________________31 1.9 The potential for natural products in pediculosis therapy ______________________32 1.10 Plant derived insecticides _______________________________________________32 1.11 Plant derived pediculicides ______________________________________________34 1.12 Essential oils and terpenoids _____________________________________________36 Evidence for the efficacy of essential oils and monoterpenoids as pediculicides ________________40 1.13 Rationale for investigating monoterpenoid mode of action ____________________41 1.14 GABAergic neurotransmission___________________________________________42 1.15 Structure and function of ionotropic GABA receptors ________________________43 1.16 Vertebrate GABA^ receptors: Molecular biology and subunit composition _______45 1.17 Insect GABA receptors: Molecular biology and subunit composition ____________46 1.18 Ionotropic GABA receptors: Allosteric proteins_____________________________48 1.19 Ionotropic GABA receptors: Pharmacology ________________________________51 Barbiturates ______________________________________________________________________________54 Steroids and propofol ______________________________________________________________________55 Hexachlorocyclohexanes __________________________________________________________________55 Benzodiazepines _________________________________________________________________________55 1.20 Natural Products provide potential and confirmed GABA receptor ligands ______57 1.21 Monoterpenoids and other volatile natural products affect the activity and ionic balance of nerve and muscle cells _____________________________________________60 Summary and direction ____________________________________________________________________63 Chapter 2 Monoterpenoids and essential oils as pediculicidal agents_____________64 2.1 Methods______________________________________________________________64 2.1.1 The Orlando strain of clothing louse as a model organism in for vitro pediculicide bioassays_ 64 2.1.2 The in vitro pediculicide bioassay________________________________________________________69 2.1.3 Observing physiological and behavioural effects of test substances_________________________70 2.1.4 Method for assaying effects of test substances on movement and behaviour of___________ lice 70 2.1.5 In vitro assessment o f ovicidal assay_____________________________________________________71 2.1.6 Method for assessing ovicidal activity ___________________________________________________71 2.1.7 A potential alternative pediculicide screen - The house dust m__________________________ ite 74 2.1.8 The house dust mite: Method of propagation_____________________________________________77 2.1.9 Testing for acaricidal activity___________________________________________________________77 2.1.10 The ‘mite chamber’ acaricidal bioassay_________________________________________________78 2.2 Results and discussion ___________________________________________________79 2.2.1 Monoterpenoids as pediculicidal agents__________________________________________________79 The relative pediculicidal activity of monoterpenoids ________________________________________79 The relationship between monoterpenoid structure and peduculicidal activity __________________80 Development of the pediculicidal test for use as a screen in pharmacognosy ____________________85 2.2.2
Recommended publications
  • Retention Indices for Frequently Reported Compounds of Plant Essential Oils
    Retention Indices for Frequently Reported Compounds of Plant Essential Oils V. I. Babushok,a) P. J. Linstrom, and I. G. Zenkevichb) National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA (Received 1 August 2011; accepted 27 September 2011; published online 29 November 2011) Gas chromatographic retention indices were evaluated for 505 frequently reported plant essential oil components using a large retention index database. Retention data are presented for three types of commonly used stationary phases: dimethyl silicone (nonpolar), dimethyl sili- cone with 5% phenyl groups (slightly polar), and polyethylene glycol (polar) stationary phases. The evaluations are based on the treatment of multiple measurements with the number of data records ranging from about 5 to 800 per compound. Data analysis was limited to temperature programmed conditions. The data reported include the average and median values of retention index with standard deviations and confidence intervals. VC 2011 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved. [doi:10.1063/1.3653552] Key words: essential oils; gas chromatography; Kova´ts indices; linear indices; retention indices; identification; flavor; olfaction. CONTENTS 1. Introduction The practical applications of plant essential oils are very 1. Introduction................................ 1 diverse. They are used for the production of food, drugs, per- fumes, aromatherapy, and many other applications.1–4 The 2. Retention Indices ........................... 2 need for identification of essential oil components ranges 3. Retention Data Presentation and Discussion . 2 from product quality control to basic research. The identifi- 4. Summary.................................. 45 cation of unknown compounds remains a complex problem, in spite of great progress made in analytical techniques over 5.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2017/0020892 A1 Thompson Et Al
    US 20170020892A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2017/0020892 A1 Thompson et al. (43) Pub. Date: Jan. 26, 2017 (54) USE OF NEGATIVE MODULATORS OF Related U.S. Application Data GABA RECEPTORS CONTAINING ALPHAS SUBUNITS AS FAST ACTING (60) Provisional application No. 61/972,446, filed on Mar. ANTDEPRESSANTS 31, 2014. (71) Applicant: University of Maryland, Baltimore, Publication Classification Baltimore, MD (US) (51) Int. Cl. A 6LX 3/557 (2006.01) (72) Inventors: Scott Thompson, Baltimore, MD (US); A6II 3/53 (2006.01) Mark D. Kvarta, Ellicott City, MD A6II 45/06 (2006.01) (US); Adam Van Dyke, Baltimore, MD (52) U.S. Cl. (US) CPC ........... A61 K3I/55.17 (2013.01); A61K 45/06 (2013.01); A61 K3I/53 (2013.01) (73) Assignee: University of Maryland, Baltimore, Baltimore, MD (US) (57) ABSTRACT Embodiments of the disclosure include methods and com (21) Appl. No.: 15/300,984 positions related to treatment of one or more medical conditions with one or more negative modulators of GABA (22) PCT Filed: Mar. 31, 2015 receptors. In specific embodiments, depression and/or Sui cidability is treated or ameliorated or prevented with one or (86) PCT No.: PCT/US2O15/023667 more negative modulators of GABA receptors, such as a S 371 (c)(1), partial inverse agonist of a GABA receptor comprising an (2) Date: Sep. 30, 2016 alpha5 subunit. Patent Application Publication Jan. 26, 2017. Sheet 1 of 12 US 2017/002O892 A1 ×1/ /|\ Patent Application Publication Jan. 26, 2017. Sheet 3 of 12 US 2017/002O892 A1 & Patent Application Publication Jan.
    [Show full text]
  • Picrotoxin-Like Channel Blockers of GABAA Receptors
    COMMENTARY Picrotoxin-like channel blockers of GABAA receptors Richard W. Olsen* Department of Molecular and Medical Pharmacology, Geffen School of Medicine, University of California, Los Angeles, CA 90095-1735 icrotoxin (PTX) is the prototypic vous system. Instead of an acetylcholine antagonist of GABAA receptors (ACh) target, the cage convulsants are (GABARs), the primary media- noncompetitive GABAR antagonists act- tors of inhibitory neurotransmis- ing at the PTX site: they inhibit GABAR Psion (rapid and tonic) in the nervous currents and synapses in mammalian neu- system. Picrotoxinin (Fig. 1A), the active rons and inhibit [3H]dihydropicrotoxinin ingredient in this plant convulsant, struc- binding to GABAR sites in brain mem- turally does not resemble GABA, a sim- branes (7, 9). A potent example, t-butyl ple, small amino acid, but it is a polycylic bicyclophosphorothionate, is a major re- compound with no nitrogen atom. The search tool used to assay GABARs by compound somehow prevents ion flow radio-ligand binding (10). through the chloride channel activated by This drug target appears to be the site GABA in the GABAR, a member of the of action of the experimental convulsant cys-loop, ligand-gated ion channel super- pentylenetetrazol (1, 4) and numerous family. Unlike the competitive GABAR polychlorinated hydrocarbon insecticides, antagonist bicuculline, PTX is clearly a including dieldrin, lindane, and fipronil, noncompetitive antagonist (NCA), acting compounds that have been applied in not at the GABA recognition site but per- huge amounts to the environment with haps within the ion channel. Thus PTX major agricultural economic impact (2). ͞ appears to be an excellent example of al- Some of the other potent toxicants insec- losteric modulation, which is extremely ticides were also radiolabeled and used to important in protein function in general characterize receptor action, allowing and especially for GABAR (1).
    [Show full text]
  • Species List 02/11/2017
    1 of 27 Kelvingrove Park - species list 02/11/2017 Group Taxon Common Name Earliest Latest Records acarine Hydracarina 2004 2004 1 amphibian Bufo bufo Common Toad 2014 2014 2 amphibian Lissotriton helveticus Palmate Newt 2006 2006 1 amphibian Lissotriton vulgaris Smooth Newt 1997 1997 1 amphibian Rana temporaria Common Frog 2009 2017 6 annelid Alboglossiphonia heteroclita 2003 2004 2 annelid Erpobdella testacea 2003 2003 1 annelid Glossiphonia complanata 2003 2003 1 annelid Helobdella stagnalis 2003 2014 3 annelid Lumbricus terrestris Common Earthworm 1996 2000 1 annelid Naididae 2004 2004 1 annelid Tubificidae Tubificid Worm Sp. 2003 2004 2 bird Acanthis flammea Common (Mealy) Redpoll 1991 1991 1 bird Accipiter nisus Sparrowhawk 1983 2008 7 bird Aegithalos caudatus Long-tailed Tit 1991 2017 16 bird Aix galericulata Mandarin Duck 1969 1969 1 bird Alcedo atthis Kingfisher 1988 2017 27 bird Anas penelope Wigeon 1994 1994 1 bird Anas platyrhynchos Mallard 1968 2014 246 bird Anser anser Greylag Goose 1973 1973 1 bird Apus apus Swift 2008 2014 4 bird Ardea cinerea Grey Heron 1991 2014 28 bird Aythya ferina Pochard 1939 1994 10 bird Aythya fuligula Tufted Duck 1992 2004 16 bird Bucephala clangula Goldeneye 1991 2006 59 bird Carduelis carduelis Goldfinch 1998 2014 12 bird Certhia familiaris Treecreeper 1995 2017 11 bird Chloris chloris Greenfinch 1988 2016 7 bird Chroicocephalus ridibundus Black-headed Gull 1961 2014 16 bird Cinclus cinclus Dipper 1991 2014 8 bird Columba livia Feral Pigeon 1958 2015 21 bird Columba oenas Stock Dove 2014 2015 2 bird Columba palumbus Woodpigeon 2014 2014 7 bird Corvus corone Carrion Crow 2014 2014 1 2 of 27 Kelvingrove Park - species list 02/11/2017 Group Taxon Common Name Earliest Latest Records bird Corvus corone agg.
    [Show full text]
  • Valerenic Acid Potentiates and Inhibits GABAA Receptors: Molecular Mechanism and Subunit Specificity
    ARTICLE IN PRESS + MODEL Neuropharmacology xx (2007) 1e10 www.elsevier.com/locate/neuropharm Valerenic acid potentiates and inhibits GABAA receptors: Molecular mechanism and subunit specificity S. Khom a, I. Baburin a, E. Timin a, A. Hohaus a, G. Trauner b, B. Kopp b, S. Hering a,* a Department of Pharmacology and Toxicology, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria b Department of Pharmacognosy, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria Received 8 December 2006; received in revised form 11 April 2007; accepted 30 April 2007 Abstract Valerian is a commonly used herbal medicinal product for the treatment of anxiety and insomnia. Here we report the stimulation of chloride currents through GABAA receptors (IGABA) by valerenic acid (VA), a constituent of Valerian. To analyse the molecular basis of VA action, we expressed GABAA receptors with 13 different subunit compositions in Xenopus oocytes and measured IGABA using the two-microelectrode voltage-clamp technique. We report a subtype-dependent stimulation of IGABA by VA. Only channels incorporating b2 or b3 subunits were stimulated by VA. Replacing b2/3 by b1 drastically reduced the sensitivity of the resulting GABAA channels. The stimulatory effect of VA on a1b2 receptors was substantially reduced by the point mutation b2N265S (known to inhibit loreclezole action). Mutating the corresponding residue of b1 (b1S290N) induced VA sensitivity in a1b1S290N comparable to a1b2 receptors. Modulation of IGABA was not significantly dependent on incorporation of a1, a2, a3 or a5 subunits. VA displayed a significantly lower efficiency on channels incorporating a4 subunits. IGABA modulation by VA was not g subunit dependent and not inhibited by flumazenil (1 mM).
    [Show full text]
  • GABA Receptors
    D Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews Review No.7 / 1-2011 GABA receptors Wolfgang Froestl , CNS & Chemistry Expert, AC Immune SA, PSE Building B - EPFL, CH-1015 Lausanne, Phone: +41 21 693 91 43, FAX: +41 21 693 91 20, E-mail: [email protected] GABA Activation of the GABA A receptor leads to an influx of chloride GABA ( -aminobutyric acid; Figure 1) is the most important and ions and to a hyperpolarization of the membrane. 16 subunits with γ most abundant inhibitory neurotransmitter in the mammalian molecular weights between 50 and 65 kD have been identified brain 1,2 , where it was first discovered in 1950 3-5 . It is a small achiral so far, 6 subunits, 3 subunits, 3 subunits, and the , , α β γ δ ε θ molecule with molecular weight of 103 g/mol and high water solu - and subunits 8,9 . π bility. At 25°C one gram of water can dissolve 1.3 grams of GABA. 2 Such a hydrophilic molecule (log P = -2.13, PSA = 63.3 Å ) cannot In the meantime all GABA A receptor binding sites have been eluci - cross the blood brain barrier. It is produced in the brain by decarb- dated in great detail. The GABA site is located at the interface oxylation of L-glutamic acid by the enzyme glutamic acid decarb- between and subunits. Benzodiazepines interact with subunit α β oxylase (GAD, EC 4.1.1.15). It is a neutral amino acid with pK = combinations ( ) ( ) , which is the most abundant combi - 1 α1 2 β2 2 γ2 4.23 and pK = 10.43.
    [Show full text]
  • Treatment Protocol Copyright © 2018 Kostoff Et Al
    Prevention and reversal of Alzheimer's disease: treatment protocol Copyright © 2018 Kostoff et al PREVENTION AND REVERSAL OF ALZHEIMER'S DISEASE: TREATMENT PROTOCOL by Ronald N. Kostoffa, Alan L. Porterb, Henry. A. Buchtelc (a) Research Affiliate, School of Public Policy, Georgia Institute of Technology, USA (b) Professor Emeritus, School of Public Policy, Georgia Institute of Technology, USA (c) Associate Professor, Department of Psychiatry, University of Michigan, USA KEYWORDS Alzheimer's Disease; Dementia; Text Mining; Literature-Based Discovery; Information Technology; Treatments Prevention and reversal of Alzheimer's disease: treatment protocol Copyright © 2018 Kostoff et al CITATION TO MONOGRAPH Kostoff RN, Porter AL, Buchtel HA. Prevention and reversal of Alzheimer's disease: treatment protocol. Georgia Institute of Technology. 2018. PDF. https://smartech.gatech.edu/handle/1853/59311 COPYRIGHT AND CREATIVE COMMONS LICENSE COPYRIGHT Copyright © 2018 by Ronald N. Kostoff, Alan L. Porter, Henry A. Buchtel Printed in the United States of America; First Printing, 2018 CREATIVE COMMONS LICENSE This work can be copied and redistributed in any medium or format provided that credit is given to the original author. For more details on the CC BY license, see: http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License<http://creativecommons.org/licenses/by/4.0/>. DISCLAIMERS The views in this monograph are solely those of the authors, and do not represent the views of the Georgia Institute of Technology or the University of Michigan. This monograph is not intended as a substitute for the medical advice of physicians. The reader should regularly consult a physician in matters relating to his/her health and particularly with respect to any symptoms that may require diagnosis or medical attention.
    [Show full text]
  • Mixed Antagonistic Effects of the Ginkgolides at Recombinant Human R1 GABAC Receptors
    Neuropharmacology 63 (2012) 1127e1139 Contents lists available at SciVerse ScienceDirect Neuropharmacology journal homepage: www.elsevier.com/locate/neuropharm Mixed antagonistic effects of the ginkgolides at recombinant human r1 GABAC receptors Shelley H. Huang a, Trevor M. Lewis b, Sarah C.R. Lummis c, Andrew J. Thompson c, Mary Chebib d, Graham A.R. Johnston a, Rujee K. Duke a,* a Discipline of Pharmacology, School of Medical Sciences, Faculty of Medicine, University of Sydney, Australia b School of Medical Sciences, University of New South Wales, Australia c Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom d Faculty of Pharmacy, University of Sydney, Australia article info abstract Article history: The diterpene lactones of Ginkgo biloba, ginkgolides A, B and C are antagonists at a range of Cys-loop Received 11 July 2011 receptors. This study examined the effects of the ginkgolides at recombinant human r1 GABAC recep- Received in revised form tors expressed in Xenopus oocytes using two-electrode voltage clamp. The ginkgolides were moderately 18 June 2012 potent antagonists with IC sinthemM range. At 10 mM, 30 mM and 100 mM, the ginkgolides caused Accepted 24 June 2012 50 rightward shifts of GABA doseeresponse curves and reduced maximal GABA responses, characteristic of noncompetitive antagonists, while the potencies showed a clear dependence on GABA concentration, Keywords: indicating apparent competitive antagonism. This suggests that the ginkgolides exert a mixed-type Ginkgolide Bilobalide antagonism at the r1 GABAC receptors. The ginkgolides did not exhibit any obvious use-dependent Mixed-antagonism inhibition. Fitting of the data to a number of kinetic schemes suggests an allosteric inhibition as Use-dependent a possible mechanism of action of the ginkgolides which accounts for their inhibition of the responses GABAr receptor without channel block or use-dependent inhibition.
    [Show full text]
  • Ligand-Gated Ion Channels' British Journal of Pharmacology, Vol
    Edinburgh Research Explorer The Concise Guide to PHARMACOLOGY 2015/16 Citation for published version: Alexander, SP, Peters, JA, Kelly, E, Marrion, N, Benson, HE, Faccenda, E, Pawson, AJ, Sharman, JL, Southan, C, Davies, JA & CGTP Collaborators 2015, 'The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels' British Journal of Pharmacology, vol. 172, no. 24, pp. 5870-5903. DOI: 10.1111/bph.13350 Digital Object Identifier (DOI): 10.1111/bph.13350 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: British Journal of Pharmacology General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 05. Apr. 2019 S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels. British Journal of Pharmacology (2015) 172, 5870–5903 THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Ligand-gated ion channels Stephen PH Alexander1,
    [Show full text]
  • Cell Surface Mobility of GABAB Receptors Saad Bin
    Cell surface mobility of GABAB receptors Saad Bin Hannan September 2011 A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy of the University College London Department of Neuroscience, Physiology, and Pharmacology University College London Gower Street London WC1E 6BT UK Declaration ii ‘I, Saad Hannan confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis.' ____________________ Saad Hannan September 2011 To Ammu, Abbu, Polu Abstract ivi Abstract Type-B γ-aminobutyric acid receptors (GABABRs) are important for mediating slow inhibition in the central nervous system and the kinetics of their internalisation and lateral mobility will be a major determinant of their signalling efficacy. Functional GABABRs require R1 and R2 subunit co-assembly, but how heterodimerisation affects the trafficking kinetics of GABABRs is unknown. Here, an α- bungarotoxin binding site (BBS) was inserted into the N-terminus of R2 to monitor receptor mobility in live cells. GABABRs are internalised via clathrin- and dynamin- dependent pathways and recruited to endosomes. By mutating the BBS, a new technique was developed to differentially track R1a and R2 simultaneously, revealing the subunits internalise as heteromers and that R2 dominantly-affects constitutive internalisation of GABABRs. Notably, the internalisation profile of R1aR2 heteromers, but not R1a homomers devoid of their ER retention motif (R1ASA), is similar to R2 homomers in heterologous systems. The internalisation of R1aASA was slowed to that of R2 by mutating a di-leucine motif in the R1 C-terminus, indicating a new role for heterodimerisation, whereby R2 subunits slow the internalization of surface GABABRs.
    [Show full text]
  • Molecular Structure and Physiological Function of Chloride Channels
    Physiol Rev 82: 503–568, 2002; 10.1152/physrev.00029.2001. Molecular Structure and Physiological Function of Chloride Channels THOMAS J. JENTSCH, VALENTIN STEIN, FRANK WEINREICH, AND ANSELM A. ZDEBIK Zentrum fu¨r Molekulare Neurobiologie Hamburg, Universita¨t Hamburg, Hamburg, Germany I. Introduction 504 II. Cellular Functions of Chloride Channels 506 A. Plasma membrane channels 506 B. Channels of intracellular organelles 507 III. The CLC Chloride Channel Family 508 A. General features of CLC channels 510 B. ClC-0: the Torpedo electric organ ClϪ channel 516 C. ClC-1: a muscle-specific ClϪ channel that stabilizes the membrane voltage 517 D. ClC-2: a broadly expressed channel activated by hyperpolarization, cell swelling, and acidic pH 519 Ϫ E. ClC-K/barttin channels: Cl channels involved in transepithelial transport in the kidney and the Downloaded from inner ear 523 F. ClC-3: an intracellular ClϪ channel that is present in endosomes and synaptic vesicles 525 G. ClC-4: a poorly characterized vesicular channel 527 H. ClC-5: an endosomal channel involved in renal endocytosis 527 I. ClC-6: an intracellular channel of unknown function 531 J. ClC-7: a lysosomal ClϪ channel whose disruption leads to osteopetrosis in mice and humans 531 K. CLC proteins in model organisms 532 on October 3, 2014 IV. Cystic Fibrosis Transmembrane Conductance Regulator: a cAMP-Activated Chloride Channel 533 A. Structure and function of the CFTR ClϪ channel 533 B. Cellular regulation of CFTR activity 534 C. CFTR as a regulator of other ion channels 534 V. Swelling-Activated Chloride Channels 535 A. Biophysical characteristics of swelling-activated ClϪ currents 536 B.
    [Show full text]
  • Soy Isoflavones: Database Development, Estrogenic Activity of Glycitein and Hypocholesterolemic Effect of Daidzein Tongtong Song Iowa State University
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1998 Soy isoflavones: database development, estrogenic activity of glycitein and hypocholesterolemic effect of daidzein Tongtong Song Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Agriculture Commons, Food Science Commons, and the Human and Clinical Nutrition Commons Recommended Citation Song, Tongtong, "Soy isoflavones: database development, estrogenic activity of glycitein and hypocholesterolemic effect of daidzein " (1998). Retrospective Theses and Dissertations. 12528. https://lib.dr.iastate.edu/rtd/12528 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly fi-om the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter fece, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion.
    [Show full text]